Riskpilot← Back to searchSign inGet full access3Diva AB
ABActiveOrg 5590149794Ingelstadsvägen 33Research and experimental development on natural sciences and engineering · NACE 7210Est. 20150 employees
Revenue 2025
SEK 0
EBITDA margin
—
+21% vs 2024
Equity ratio
100.0%
Financial strength
Net profit 2025
SEK 20K
+227% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -12K | +21% |
| Net profit | SEK 20K | +227% |
| Total assets | SEK 605K | +2% |
| Equity | SEK 605K | +3% |
| Employees | 0 | — |
Legal name
3Diva AB
Org number
5590149794
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
26 maj 2015
Share capital
SEK 65 810
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas i förening av Fohlman, Jan Peter Arne Thunander, Eva Maria CeciliaDessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Aktiebolaget ska bedriva utveckling av vacciner.
Address
Ingelstadsvägen 33
Email
janfoh@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 100 | — | — | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −26 | 70 | −11 | −16 | −12 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −26 | 70 | −11 | −16 | −12 |
| Net financials | — | — | — | 0 | 0 |
| Profit before tax | −26 | 70 | −11 | −16 | −12 |
| Tax | −0 | — | — | — | 32 |
| Net profit | −26 | 70 | −11 | −16 | 20 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 632 | 615 | 604 | 594 | 605 |
| Equity | 541 | 611 | 600 | 585 | 605 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 91 | 4 | 4 | 9 | 0 |
| Total debt | 91 | 4 | 4 | 9 | — |
EBITDA margin
-1240400.0%
This company
15.8%
Market median
-7850733% vs market
20212025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20212025
Return on equity
3.3%
This company
18.4%
Market median
-82% vs market
20212025
Net profit margin
1998500.0%
This company
8.1%
Market median
+24672740% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HW Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of 3Diva AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans William Quiding | Chief Executive Officer | 0 companies |
| Bror Gunnar Vilhelm Morein | Deputy Board Member | 0 companies |
| Eva Maria Cecilia Thunander | Board of Directors | 0 companies |
| Alexander Philip Ken Shaps | Board of Directors | 0 companies |
| Gunvor Mona Marianne Olsson | Board of Directors | 0 companies |
| Torbjörn Åkerfeldt | Deputy Board Member | 0 companies |
| Jan Peter Arne Fohlman | Chairman | 0 companies |